Kaylie D Jones1, Alina Radziwon2, David G Birch1,3, Ian M MacDonald2. 1. Retina Foundation of the S.W ., Dallas, TX, USA. 2. Department of Ophthalmology and Visual Sciences, University of Alberta , Edmonton, Alberta, Canada. 3. Ophthalmology, UTSW Medical Center , Dallas, TX, USA.
Abstract
BACKGROUND: Choroideremia is an X-linked retinal disease characterized by progressive atrophy of the choroid and retinal pigment epithelium caused by mutations in the CHM gene. SVA (SINE-R/VNTR/Alu) elements are a type of non-autonomous retrotransposon that occasionally self-replicate, reinsert randomly into a gene, and cause disease. Intragenic SVA insertions have been reported as the mechanism underlying a number of diseases including a syndromic form of retinal dystrophy, but have never been found in CHM. MATERIALS AND METHODS: Here we identified and characterized a novel hemizygous SVA insertion, c.97_98inSVA (p.Arg33insSVA), in exon 2 of CHM in a male choroideremia patient. The SVA insertion's impact was evaluated by establishing a patient-derived lymphoblastoid cell line as a source of RNA for mRNA analysis of the CHM transcript, and protein for immunoblot analysis of Rab Escort Protein 1 (REP-1). RESULTS: Immunoblot analysis revealed the absence of REP-1 protein, while a smaller than expected PCR product was amplified from cDNA. Sequencing of this PCR product showed skipping of exon 2, denoted r.50_116del. Ophthalmic examination including psychophysical tests, visual electrophysiology, and fundus imaging showed the patient's phenotype was consistent with severe early manifestations of choroideremia. CONCLUSIONS: This case is the first report of a SVA insertion in the CHM gene causing choroideremia.
BACKGROUND:Choroideremia is an X-linked retinal disease characterized by progressive atrophy of the choroid and retinal pigment epithelium caused by mutations in the CHM gene. SVA (SINE-R/VNTR/Alu) elements are a type of non-autonomous retrotransposon that occasionally self-replicate, reinsert randomly into a gene, and cause disease. Intragenic SVA insertions have been reported as the mechanism underlying a number of diseases including a syndromic form of retinal dystrophy, but have never been found in CHM. MATERIALS AND METHODS: Here we identified and characterized a novel hemizygous SVA insertion, c.97_98inSVA (p.Arg33insSVA), in exon 2 of CHM in a male choroideremiapatient. The SVA insertion's impact was evaluated by establishing a patient-derived lymphoblastoid cell line as a source of RNA for mRNA analysis of the CHM transcript, and protein for immunoblot analysis of Rab Escort Protein 1 (REP-1). RESULTS: Immunoblot analysis revealed the absence of REP-1 protein, while a smaller than expected PCR product was amplified from cDNA. Sequencing of this PCR product showed skipping of exon 2, denoted r.50_116del. Ophthalmic examination including psychophysical tests, visual electrophysiology, and fundus imaging showed the patient's phenotype was consistent with severe early manifestations of choroideremia. CONCLUSIONS: This case is the first report of a SVA insertion in the CHM gene causing choroideremia.
Entities:
Keywords:
CHM ; REP-1; SVA insertion; choroideremia; retrotransposon
Authors: Dustin C Hancks; John L Goodier; Prabhat K Mandal; Ling E Cheung; Haig H Kazazian Journal: Hum Mol Genet Date: 2011-06-02 Impact factor: 6.150
Authors: Alina Radziwon; Gavin Arno; Dianna K Wheaton; Ellen M McDonagh; Emma L Baple; Kaylie Webb-Jones; David G Birch; Andrew R Webster; Ian M MacDonald Journal: Hum Mutat Date: 2017-03-24 Impact factor: 4.878
Authors: José A J M van den Hurk; Dorien J R van de Pol; Bernd Wissinger; Marc A van Driel; Lies H Hoefsloot; Ilse J de Wijs; L Ingeborgh van den Born; John R Heckenlively; Han G Brunner; Eberhart Zrenner; Hans-Hilger Ropers; Frans P M Cremers Journal: Hum Genet Date: 2003-06-25 Impact factor: 4.132
Authors: T L Edwards; J Williams; M I Patrício; M P Simunovic; M Shanks; P Clouston; R E MacLaren Journal: Clin Genet Date: 2017-04-19 Impact factor: 4.438